Regentis Biomaterials (RGNT) Retained Earnings (2024 - 2025)

Regentis Biomaterials' (RGNT) quarterly Retained Earnings came in at -$55.8 million in Q4 2025, down 32.38% year-on-year from -$82.5 million in Q4 2024, and down 32.38% on a QoQ basis from -$42.1 million in Q4 2024.

Regentis Biomaterials (RGNT) Retained Earnings (2024 - 2025) Analysis & Trends

Regentis Biomaterials (RGNT) has 2 years of Retained Earnings data on file, last reported at -$55.8 million in Q4 2025.

  • On a quarterly basis, Retained Earnings fell 32.38% year-over-year to -$55.8 million in Q4 2025; TTM through Dec 2025 was -$55.8 million, a 32.38% decrease from a year earlier, with the FY2025 full-year figure at -$55.8 million, down 32.38% from the prior year.
  • Retained Earnings for Q4 2025 stood at -$55.8 million, down from -$42.1 million in the prior quarter.
  • Over the last five years, Retained Earnings for RGNT reached as high as -$42.1 million in Q4 2024 and fell as low as -$55.8 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 22.11 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 6.84 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -1.76 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 122.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -24.91 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 4.62 Bn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 1.98 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 1.81 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 2.55 Bn
10 Regentis Biomaterials 1.10 Mn -6.28 Mn - -55.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -55.79 Mn
Dec 31, 2024 -42.15 Mn